Painless gastrointestinal endoscopy
Conditions
Interventions
Experimental group1:propofol 3.5ug/ml+butorphanol5ug/kg
Experimental group2:propofol 3.5ug/ml+butorphanol10ug/kg
Experimental group3:propofol 3.5ug/ml+sufentanil0.05ug/kg
control group:normal saline
Sponsors
The 2nd Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. undergoing gastrointestinal endoscopy; 2. ASAI-II; 3. Aged 18-65 years old; 4. BMI 18 to 25kg/m2; 5. operate by the same endoscopist.
Exclusion criteria
Exclusion criteria: 1. To be allergic to propofol; 2. have ever suffered from glaucoma , prostatomegaly ,diabetes or hyperthyreosis; 3. plan to be conducted endoscopic treatment; 4. have ever suffered from abdominal operation; 5. mental, neurological disease; 6.organ dysfunction (liver,kindy,brain,lung failure); 7. sleep apnea syndrome.8.long-term opioid administration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the total consumption of propofol;D-value of MAP between baseline and the messureing time point; | — |
Secondary
| Measure | Time frame |
|---|---|
| the satisfaction degree of endoscopist;D-value of MAP between baseline and the messureing time point;D-value of MAP between baseline and the messureing time point;D-value of MAP between baseline and the messureing time point;D-value of MAP between baseline and the messureing time point;The duration of gastroscopy;The duration of colonoscopy;the satisfaction degree of patients;injection pain score;Ramsay score of patients; | — |
Countries
China
Contacts
Public ContactRuifeng Zeng
Department of Anesthesiology, The 2nd Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed